Specialities Pharmaceuticals

This unit has a wide and diverse client base and covers both Private and Institutional sectors. Private sector deals with private pharmacies and private hospitals whereas; Institutional sector deals with Ministries, Charitable Societies, and Government subsidiaries etc.

Commenced operations since 1960, and continuously offering top quality pharmaceutical brands that are approved by FDA and/or EMA.

Addressing the growing requirements of patients, physicians, health care payers with emphasis on specialty-focused innovative medicines that provide significant clinical benefit and value, primarily in the therapeutic areas of:

  • Osteoporosis
  • Osteoarthritis
  • Parkinson’s disease
  • Pain-Management
  • Psychotic conditions
  • Depressive and general anxiety disorders
  • Deficit Hyperactivity Disorder
  • Peyronie’s disease
  • Zyprexa®
  • Strattera®
  • Cymbalta®
  • Forteo®
  • Tramal®
  • Zaldiar®
  • Versatis®
  • Apo Go®
  • Xiaflex®
  • Synvisc one ®